Bruker Corporation Net Income 2011-2026 | BRKR

Net profit is a financial indicator that reflects the remaining amount of money after deducting all expenses and taxes from the company’s total income over a certain period of time. It is one of the key indicators of a company’s financial stability and success.

Net profit is the portion of total profit remaining after taxes and depreciation have been deducted.^[1]

It is the result of a company’s operations and reflects its efficiency in managing resources, controlling expenses, and generating income. It includes all operating revenues and expenses, such as sales of goods or services, production costs, administrative expenses, taxes, and other financial metrics.

The calculation of net profit includes the deduction of all necessary expenses such as employee salaries, rent, utilities, taxes, and other mandatory payments. After all these expenses are deducted from the total income, the remaining amount is considered the company’s net profit.

Net profit is an important indicator of a company’s financial health, as it reflects its ability to generate earnings and manage its finances. High net profit indicates business success, competitiveness, and efficiency in resource utilization. It also allows a company to invest in its development, pay dividends to shareholders, or create reserve funds for unforeseen situations.

It serves as a basis for calculating other financial indicators, such as return on sales, return on assets, or return on equity. It is also used to assess the performance of management and make decisions regarding the future development of the company.

However, it should be noted that net profit can be affected by various factors, such as economic conditions, changes in legislation, market competition, and other external influences. Therefore, companies must be prepared for possible changes and take measures to ensure the stability of their financial results.

Annual Net Income Bruker Corporation

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
113 M	427 M	297 M	277 M	158 M	197 M	180 M	78.6 M	154 M	102 M	56.7 M	80.1 M	77.5 M	92.3 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
427 M	56.7 M	164 M

Quarterly Net Income Bruker Corporation

2025-Q3	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-59.6 M	17.4 M	-	40.9 M	7.6 M	50.9 M	-	88.1 M	57.1 M	76.5 M	-	88.1 M	49.5 M	61.6 M	-	87.1 M	57.6 M	56.7 M	-	54.3 M	24.1 M	10.5 M	68.6 M	61.3 M	36.5 M	30.8 M	78.1 M	43.4 M	31.2 M	27 M	-3.4 M	37 M	23.4 M	21.6 M	69 M	46.5 M	14.5 M	23.6 M	61.4 M	11.8 M	21.9 M	6.5 M	26.1 M	5.5 M	16.4 M	8.7 M	35.2 M	16.6 M	22.9 M	5.4 M	12.8 M	39.7 M	9.9 M	15.1 M	39.1 M	19.8 M	22.1 M	11.3 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
88.1 M	-59.6 M	33.7 M

References

Bhamornsiri, S., & Wiggins, C. (2001). Comprehensive income disclosures. The CPA Journal, 71(10), 54.

Net Income of other stocks in the Medical devices industry

Issuer	Net Income	Price	% 24h	Market Cap	Country
EDAP TMS S.A. EDAP	-21.2 M	$ 3.71	-5.12 %	$ 138 M	France
GenMark Diagnostics, Inc. GNMK	-18.6 M	-	-	$ 1.77 B	USA
Axonics Modulation Technologies AXNX	-59.7 M	-	-	$ 3.31 B	USA
Aziyo Biologics AZYO	53.4 M	-	1.37 %	$ 20.5 M	USA
Profound Medical Corp. PROF	-30.7 M	$ 5.82	13.01 %	$ 180 M	Canada
Acutus Medical AFIB	-81.7 M	-	-26.83 %	$ 2.62 M	USA
BioSig Technologies BSGM	-10.3 M	-	37.08 %	$ 85.7 M	USA
Allied Healthcare Products AHPI	-1.94 M	-	3.58 %	$ 2.21 M	USA
Obalon Therapeutics, Inc. OBLN	-12.3 M	-	-5.86 %	$ 30.6 M	USA
Conformis CFMS	-50.5 M	-	-	$ 16.4 M	USA
Delcath Systems DCTH	2.7 M	$ 9.2	2.45 %	$ 330 M	USA
Dynatronics Corporation DYNT	-10.9 M	-	14.99 %	$ 929 K	USA
Cardiovascular Systems CSII	-36.9 M	-	0.15 %	$ 844 M	USA
Second Sight Medical Products EYES	-23.5 M	-	-0.97 %	$ 54.4 M	USA
Apollo Endosurgery APEN	-39.8 M	-	-	$ 475 M	USA
Avinger AVGR	-18.3 M	-	-20.74 %	$ 369 K	USA
CryoLife, Inc. CRY	-16.7 M	-	-4.14 %	$ 702 M	USA
CONMED Corporation CNMD	47.1 M	$ 37.08	1.42 %	$ 1.15 B	USA
Smith & Nephew plc SNN	524 M	-	-	$ 23.8 B	Britain
Soliton, Inc. SOLY	-14.5 M	-	-1.42 %	$ 435 M	USA
Hancock Jaffe Laboratories, Inc. HJLI	-9.14 K	-	-1.98 %	$ 98.3 M	USA
Itamar Medical Ltd. ITMR	-10.9 M	-	0.03 %	$ 1.58 B	Israel
Electromed ELMD	7.54 M	$ 24.66	-0.16 %	$ 208 M	USA
Misonix, Inc. MSON	-17.4 M	-	-	$ 462 M	USA
Helius Medical Technologies HSDT	-8.85 M	$ 2.16	7.46 %	$ 1.31 M	USA
Neovasc NVCN	-24.9 M	-	-	$ 111 M	Canada
Integra LifeSciences Holdings Corporation IART	-6.94 M	$ 9.55	0.1 %	$ 735 M	USA
Intersect ENT, Inc. XENT	-72.3 M	-	-	$ 955 M	USA
Inogen INGN	-22.7 M	$ 6.42	1.58 %	$ 171 M	USA
IRIDEX Corporation IRIX	-9.57 M	$ 1.33	-1.85 %	$ 21.5 M	USA
IRadimed Corporation IRMD	22.5 M	$ 101.78	0.8 %	$ 1.29 B	USA
Cytosorbents Corporation CTSO	-20.7 M	$ 0.67	-3.52 %	$ 36.5 M	USA
Aethlon Medical AEMD	-13.4 M	$ 2.32	7.41 %	$ 3.62 M	USA
BIOLASE BIOL	-20.6 M	-	-13.19 %	$ 166 K	USA
LivaNova PLC LIVN	-242 M	$ 63.3	1.44 %	$ 3.45 B	Britain
InspireMD NSPR	-48.8 M	$ 1.77	-1.12 %	$ 114 M	Israel
LENSAR LNSR	-31.4 M	$ 5.58	0.36 %	$ 64.3 M	USA
AdaptHealth Corp. AHCO	-70.8 M	$ 11.39	-0.78 %	$ 1.54 B	USA
Penumbra PEN	178 M	$ 336.27	0.63 %	$ 13.1 B	USA
Medtronic PLC MDT	4.66 B	$ 87.89	1.51 %	$ 113 B	USA
MiMedx Group MDXG	48.6 M	$ 4.1	-0.73 %	$ 606 M	USA
Nano-X Imaging Ltd. NNOX	-53.5 M	$ 2.29	-4.58 %	$ 134 M	Israel
Invacare Corporation IVC	-20.6 M	-	-	$ 24.7 M	USA
OrthoPediatrics Corp. KIDS	-39.6 M	$ 16.23	2.01 %	$ 381 M	USA
Myomo MYO	-15.6 M	$ 0.7	-0.1 %	$ 29.3 M	USA
NanoVibronix NAOV	-3.7 M	-	-	$ 1.08 M	USA
Inspire Medical Systems INSP	145 M	$ 51.41	-1.27 %	$ 1.51 B	USA
Orthofix Medical OFIX	-92.2 M	$ 11.93	1.79 %	$ 472 M	Curacao